Your browser doesn't support javascript.
loading
Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.
Rajoli, R K R; Podany, A T; Moss, D M; Swindells, S; Flexner, C; Owen, A; Siccardi, M.
Afiliación
  • Rajoli RKR; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Podany AT; College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Moss DM; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK, School of Pharmacy, Keele University, Newcastle, UK.
  • Swindells S; College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
  • Flexner C; Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Owen A; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Siccardi M; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Int J Tuberc Lung Dis ; 22(8): 937-944, 2018 08 01.
Article en En | MEDLINE | ID: mdl-29991405

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Latente / Antituberculosos Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Tuberc Lung Dis Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Latente / Antituberculosos Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Tuberc Lung Dis Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Francia